AREV Life Sciences Global Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CAD 43,188 compared to CAD 53,818 a year ago. Net loss was CAD 695,260 compared to CAD 275,054 a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.02 a year ago. For the half year, sales was CAD 86,528 compared to CAD 87,823 a year ago. Net loss was CAD 1.272 million compared to CAD 388,317 a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.03 a year ago.